These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


989 related items for PubMed ID: 7874668

  • 1. Clinical relationship of extrapyramidal symptoms and tardive dyskinesia.
    Andrew HG.
    Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S76-80. PubMed ID: 7874668
    [Abstract] [Full Text] [Related]

  • 2. Incidence of extrapyramidal symptoms and tardive dyskinesia in schizophrenia: thirty-six-month results from the European schizophrenia outpatient health outcomes study.
    Novick D, Haro JM, Bertsch J, Haddad PM.
    J Clin Psychopharmacol; 2010 Oct; 30(5):531-40. PubMed ID: 20814320
    [Abstract] [Full Text] [Related]

  • 3. Evolution of neuroleptic-induced extrapyramidal syndromes under long-term neuroleptic treatment.
    Modestin J, Wehrli MV, Stephan PL, Agarwalla P.
    Schizophr Res; 2008 Mar; 100(1-3):97-107. PubMed ID: 18055180
    [Abstract] [Full Text] [Related]

  • 4. Neuroleptic drug-induced extrapyramidal syndromes and tardive dyskinesia.
    Casey DE.
    Schizophr Res; 1991 Mar; 4(2):109-20. PubMed ID: 1674881
    [Abstract] [Full Text] [Related]

  • 5. [Recent research trends in diagnosis, treatment, and prevention of drug-induced extrapyramidal symptoms seen in psychiatric patients].
    Inada T.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Oct; 16(5):181-5. PubMed ID: 8962437
    [Abstract] [Full Text] [Related]

  • 6. Movement disorders associated with neuroleptic treatment.
    Wirshing WC.
    J Clin Psychiatry; 2001 Oct; 62 Suppl 21():15-8. PubMed ID: 11584982
    [Abstract] [Full Text] [Related]

  • 7. Motor and mental side effects of clozapine.
    Gerlach J, Peacock L.
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():107-9. PubMed ID: 7961551
    [Abstract] [Full Text] [Related]

  • 8. Novel antipsychotics, extrapyramidal side effects and tardive dyskinesia.
    Barnes TR, McPhillips MA.
    Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S49-57. PubMed ID: 9690971
    [Abstract] [Full Text] [Related]

  • 9. Clozapine-induced tardive dyskinesia in schizophrenic patients taking clozapine as a first-line antipsychotic drug.
    Li CR, Chung YC, Park TW, Yang JC, Kim KW, Lee KH, Hwang IK.
    World J Biol Psychiatry; 2009 Mar; 10(4 Pt 3):919-24. PubMed ID: 19995222
    [Abstract] [Full Text] [Related]

  • 10. Extrapyramidal syndromes and new antipsychotic drugs: findings in patients and non-human primate models.
    Casey DE.
    Br J Psychiatry Suppl; 1996 May; (29):32-9. PubMed ID: 8733821
    [No Abstract] [Full Text] [Related]

  • 11. Clozapine treatment of psychosis in patients with tardive dystonia: report of three cases.
    Friedman JH.
    Mov Disord; 1994 May; 9(3):321-4. PubMed ID: 7913739
    [Abstract] [Full Text] [Related]

  • 12. Neuroleptic-induced acute extrapyramidal syndromes and tardive dyskinesia.
    Casey DE.
    Psychiatr Clin North Am; 1993 Sep; 16(3):589-610. PubMed ID: 8105453
    [Abstract] [Full Text] [Related]

  • 13. Drug-induced parkinsonism: relationship to age at onset of schizophrenia.
    Sandyk R, Kay SR.
    Funct Neurol; 1991 Sep; 6(2):151-7. PubMed ID: 1680777
    [Abstract] [Full Text] [Related]

  • 14. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients.
    Spivak B, Mester R, Abesgaus J, Wittenberg N, Adlersberg S, Gonen N, Weizman A.
    J Clin Psychiatry; 1997 Jul; 58(7):318-22. PubMed ID: 9269253
    [Abstract] [Full Text] [Related]

  • 15. Movement disorders with neuroleptic drug treatment.
    Tarsy D.
    Psychiatr Clin North Am; 1984 Sep; 7(3):453-71. PubMed ID: 6148742
    [Abstract] [Full Text] [Related]

  • 16. The problem of tardive akathisia.
    Gualtieri CT.
    Brain Cogn; 1993 Sep; 23(1):102-9. PubMed ID: 8105819
    [Abstract] [Full Text] [Related]

  • 17. Metric characteristics of the drug-induced extrapyramidal symptoms scale (DIEPSS): a practical combined rating scale for drug-induced movement disorders.
    Kim JH, Jung HY, Kang UG, Jeong SH, Ahn YM, Byun HJ, Ha KS, Kim YS.
    Mov Disord; 2002 Nov; 17(6):1354-9. PubMed ID: 12465082
    [Abstract] [Full Text] [Related]

  • 18. Incidence and persistence of tardive dyskinesia and extrapyramidal symptoms in schizophrenia.
    Tenback DE, van Harten PN, Slooff CJ, van Os J.
    J Psychopharmacol; 2010 Jul; 24(7):1031-5. PubMed ID: 19487321
    [Abstract] [Full Text] [Related]

  • 19. [Current data on neurologic sequelae caused by neuroleptics].
    Krebs MO.
    Encephale; 1995 Jun; 21 Spec No 3():49-52. PubMed ID: 7628342
    [Abstract] [Full Text] [Related]

  • 20. [New chemotherapy approaches to psychoses].
    Olié JP, Baylé FJ.
    Encephale; 1997 Apr; 23 Spec No 2():2-9. PubMed ID: 9273302
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 50.